Readystate Asset Management’s Aktis Oncology AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-30,000
Closed -$967K – 1129
2026
Q2
$967K Hold
30,000
– – 0.03% 299
2026
Q1
$537K Buy
+30,000
New +$582K 0.02% 603

Other funds holding AKTS

Readystate Asset Management's AKTS Position: Q3 2026 in Review

Readystate Asset Management sold out of Aktis Oncology (AKTS) in Q3 2026, closing a stake of 30,000 shares — an estimated $967K sold.

Readystate Asset Management first reported a position in AKTS in Q1 2026 and held it in 2 quarters. The position peaked at $967K in Q2 2026. 118 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • Readystate Asset Management reported no remaining Aktis Oncology position as of Q3 2026 after selling out during the quarter.
  • Readystate Asset Management sold 30,000 Aktis Oncology shares in Q3 2026, an estimated $967K.
  • Readystate Asset Management first reported a position in Aktis Oncology in Q1 2026 and held it in 2 quarters.
  • Readystate Asset Management's Aktis Oncology position peaked at $967K in Q2 2026.
  • 118 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Readystate Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.